![Quiver Logo](/static/img/logo-icon.png)
![IMTXW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/imtxw.png)
Immatics N.V. Warrants
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IMTXW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of IMTXW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IMTXW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to IMTXW
Recent picks made for IMTXW stock on CNBC
ETFs with the largest estimated holdings in IMTXW
Flights by private jets registered to IMTXW
![Quiver Logo](/static/img/logo-icon.png)